1,093 reports of this reaction
6.1% of all DASPONE reports
#1 most reported adverse reaction
OFF LABEL USE is the #1 most commonly reported adverse reaction for DASPONE, manufactured by Amneal Pharmaceuticals NY LLC. There are 1,093 FDA adverse event reports linking DASPONE to OFF LABEL USE. This represents approximately 6.1% of all 17,982 adverse event reports for this drug.
Patients taking DASPONE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among DASPONE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for DASPONE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 1,093 FDA reports for DASPONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 6.1% of all adverse event reports for DASPONE, making it one of the most commonly reported side effect.
If you experience off label use while taking DASPONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.